Boston Scientific Corp. is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder ...

Boston Scientific Corporation BSX recently entered into a definitive agreement to acquire Bolt Medical, Inc. — an intravascular lithotripsy (IVL) advanced laser-based platform developer. The ...

Marlborough-based Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment manufacturer Bolt Medical.

Patrick Wood, an analyst from Morgan Stanley, maintained the Buy rating on Boston Scientific (BSX – Research Report). The associated price ...

Boston Scientific (NYSE:BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices company does not already own. BSX shares were trading +2.07% pre ...

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

We recently published a list of 10 Hottest Mega-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

Despite macroeconomic concerns, currency headwinds and related cost inflation, Boston Scientific Corporation BSX is seeing strength across target markets. The company is demonstrating growth backed by ...

Boston Scientific acquires Bolt Medical for $443 million upfront, with up to $221 million contingent on regulatory milestones. Bolt IVL platform uses acoustic waves to treat calcified artery ...

Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...

Jan. 8, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular ...